One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Foreword
Eggert Stockfleth, Brigitte Dréno, Daniel Bacqueville, Hélène Duplan, Ariadna Ortiz Brugués
doi : 10.1111/jdv.19007
In vivo method for evaluating sunscreen protection against high-energy visible light
J. Le Digabel, J. Filiol, C. Lauze, D. Redoulès, G. Josse
doi : 10.1111/jdv.19243
Broad-spectrum sunscreens containing the TriAsorBâ„¢ filter: In vitro photoprotection and clinical evaluation of blue light-induced skin pigmentation
France Boyer, Cécile Delsol, Virginie Ribet, Priscilla Lapalud
doi : 10.1111/jdv.19290
Climate change and air pollution: Twin threats of burning fossil fuels with implications for the practice of dermatology
Markus D. Boos
doi : 10.1111/jdv.19358
BRAF variant allele fraction�A predictor of response to targeted therapy?
Mitchell S. Stark, Teresa Harris, Douglas Grossman, Robert Judson-Torres
doi : 10.1111/jdv.19389
Pioneers in Dermatology and Venereology: An interview with Professor Gil Yosipovitch
Gil Yosipovitch
doi : 10.1111/jdv.19396
Women education in the Soviet prophylactoria and the care homes for sexually transmitted disease patients in the Soviet Occupation Zone of Germany
Maximilian Schochow, Florian Steger
doi : 10.1111/jdv.19245
Hairlines through history: Frontal fibrosing alopecia over 500 years?
Melanie Page, Khaylen Mistry, Abby E. Macbeth, Nick J. Levell
doi : 10.1111/jdv.19276
Air pollution and global healthcare use for atopic dermatitis: A systematic review
R. P. Fadadu, E. Chee, A. Jung, J. Y. Chen, K. Abuabara, M. L. Wei
doi : 10.1111/jdv.19193
Exposure to biologic therapy before and during pregnancy in patients with psoriasis: Systematic review and meta-analysis
V. Sánchez-GarcÃÂa, R. Hernández-Quiles, E. de-Miguel-Balsa, ÃÂ�. Giménez-Richarte, J. M. Ramos-Rincón, I. Belinchón-Romero
doi : 10.1111/jdv.19238
BRAFV600 variant allele frequency predicts outcome in metastatic melanoma patients treated with BRAF and MEK inhibitors
Mario Mandalà , Giuseppe Palmieri, Vienna Ludovini, Sara Baglivo, Francesca Marasciulo, Francesca Castiglione, Alessio Gili, Simona Osella Abate, Marco Rubatto, Rebecca Senetta, Gianluca Avallone, Simone Ribero, Luca Romano, Nicola Pimpinelli, Vincenzo de Giorgi, Fausto Roila, Marina Pisano, Milena Casula, Antonella Manca, Maria Cristina Sini, Daniela Massi, Pietro Quaglino, Italian Melanoma Intergroup (IMI)
doi : 10.1111/jdv.19281
Online prediction tools for melanoma survival: A comparison
A. Dixon, H. K. Steinman, A. Kyrgidis, H. Smith, M. Sladden, C. Zouboulis, G. Argenziano, Z. Apalla, A. Lallas, C. Longo, A. Nirenberg, C. Popescu, T. Tzellos, L. Cleaver, C. Zachary, S. Anderson, J. M. Thomas
doi : 10.1111/jdv.19219
Tildrakizumab improves high burden skin symptoms, impaired sleep and quality of life of moderate-to-severe plaque psoriasis patients in conditions close to clinical practice
Antonio Costanzo, Mar Llamas-Velasco, Gabriella Fabbrocini, Aldo Cuccia, Raquel Rivera-Diaz, Kristian Gaarn Du Jardin, Ismail Kasujee, LluÃÂs Puig, José Manuel Carrascosa
doi : 10.1111/jdv.19229
Early disease intervention with guselkumab in psoriasis leads to a higher rate of stable complete skin clearance (‘clinical super response’): Week 28 results from the ongoing phase IIIb randomized, double-blind, parallel-group, GUIDE study
K. Schäkel, K. Reich, K. Asadullah, A. Pinter, D. Jullien, P. Weisenseel, C. Paul, M. Gomez, S. Wegner, Y. Personke, F. Kreimendahl, Y. Chen, J. Angsana, M. W. L. Leung, K. Eyerich
doi : 10.1111/jdv.19236
Polymorphisms in corticotrophin-releasing hormone–proopiomalanocortin (CRH–POMC) system genes: Neuroimmune contributions to psoriasis disease
Elvira Galimova, Ranno Rätsep, Tanel Traks, Alexandr Chernov, Darya Gaysina, Külli Kingo, Sulev Kõks
doi : 10.1111/jdv.19257
A detailed look at the European Medicines Agency's recommendations for use of Janus kinase inhibitors in patients with atopic dermatitis
Andreas Wollenberg, Jacob P. Thyssen, Thomas Bieber, Gary Chan, Urs Kerkmann
doi : 10.1111/jdv.19255
Abrocitinib effect on patient-reported outcomes in patients with moderate-to-severe atopic dermatitis: Results from phase 3 studies, including the long-term extension JADE EXTEND study
K. Reich, J. I. Silverberg, K. A. Papp, M. Deleuran, N. Katoh, B. Strober, L. A. Beck, M. de Bruin-Weller, T. Werfel, F. Zhang, P. Biswas, M. D. DiBonaventura, G. Chan, S. A. Farooqui, U. Kerkmann, C. Clibborn
doi : 10.1111/jdv.19254
Abrocitinib efficacy and safety in patients with moderate-to-severe atopic dermatitis: Results from phase 3 studies, including the long-term extension JADE EXTEND study
Kristian Reich, Jonathan I. Silverberg, Kim A. Papp, Mette Deleuran, Norito Katoh, Bruce Strober, Lisa A. Beck, Marjolein de Bruin-Weller, Thomas Werfel, Fan Zhang, Pinaki Biswas, Marco D. DiBonaventura, Gary Chan, Susan Johnson, Saleem A. Farooqui, Urs Kerkmann, Claire Clibborn
doi : 10.1111/jdv.19280
Recombinant Treponema pallidum protein Tp47 promoted the phagocytosis of macrophages by activating NLRP3 inflammasome induced by PKM2-dependent glycolysis
Y.-W. Zheng, M. Wang, J.-W. Xie, R. Chen, X.-T. Wang, Y. He, T.-C. Yang, L.-L. Liu, L.-R. Lin
doi : 10.1111/jdv.19231
Reliable and rapid identification of terbinafine resistance in dermatophytic nail and skin infections
Gabriela Blanchard, Boyko Amarov, Marina Fratti, Karine Salamin, Olympia Bontems, Yun-Tsan Chang, Alina Marcela Sabou, Nathalie Künzle, Michel Monod, Emmanuella Guenova
doi : 10.1111/jdv.19253
Impact on facial skin aging signs of a 1-year standardized photoprotection over a classical skin care routine in skin phototypes II–VI individuals: A prospective randomized trial
F. Flament, D. G. Mercurio, E. Catalan, E. Bouhadanna, C. Delaunay, D. F. Miranda, T. Passeron
doi : 10.1111/jdv.19230
Guselkumab for the treatment of patients with moderate-to-severe hidradenitis suppurativa: A phase 2 randomized study
Alexa B. Kimball, Maurizio Podda, Afsaneh Alavi, Megan Miller, Yaung-Kaung Shen, Shu Li, Yan Xu, Chenglong Han, Steven Fakharzadeh, Ya-Wen Yang, Samuel DePrimo, Ernesto Munoz, Yanqing Chen, Thierry Passeron, Kim Papp
doi : 10.1111/jdv.19252
Hidradenitis suppurativa presents a methylome dysregulation capable to explain the pro-inflammatory microenvironment: Are these DNA methylations potential therapeutic targets?
Uppala Radhakrishna, Uppala Ratnamala, Devendrasinh D. Jhala, Lavanya V. Uppala, Aaren Vedangi, Maulikkumar Patel, Nikita Vadsaria, Sushma Shah, Nazia Saiyed, Rakesh M. Rawal, Santo Raffaele Mercuri, Gregor B. E. Jemec, Giovanni Damiani
doi : 10.1111/jdv.19286
Type 1 interferon signature and cytotoxic T lymphocyte activation targeted against sweat ducts in inflammatory acquired idiopathic generalized anhidrosis
K. Sano, M. Asahina, N. Araki, T. Uehara, M. Iwaya, R. Okuyama
doi : 10.1111/jdv.19284
How familiar are German dermatologists with placebo and nocebo effects and to what extent are these targeted in clinical practice: A survey within the dermatological community
Frederik Krefting, Stefanie Hölsken, Sven Benson, Manfred Schedlowski, Wiebke Sondermann
doi : 10.1111/jdv.19258
A case of COVID-19-related vulval ulceration coupled with genital viral shedding
E. Mastoraki, S. Niforatou-Daskalaki, C. B. Bunker, G. Kravvas
doi : 10.1111/jdv.19212
Impact of COVID-19 in patients with autoimmune bullous diseases: Report from an international registry
Joost M. Meijer, Hanan Rashid, Styliani Vergadi, Emiliano Antiga, Pamela Vezzoli, Riccardo Balestri, Aikaterini Patsatsi, Soner Uzun, Dusan Skiljevic, Hana Jedlickova, Lucia Janickova, Alberto Corrà, Alessandra Ponziani, Claudia Günther, Giuseppe Cianchini, Matthias Schefzyk, Angelo Marzano, Giovanni Di Zenzo, Iakov Shimanovich, Janet Fairley, Jose M. Mascaró Jr, Marzia Caproni, Roberto Maglie, Enno Schmidt, Barbara Horváth
doi : 10.1111/jdv.19242
Clinical and epidemiological features of psoriasis exacerbations in children with SARS-CoV-2 infection
S. Skrek, V. Di Lernia, A. Beauchet, A.-C. Bursztejn, A. Belloni Fortina, A. Lesiak, J. Thomas, P. Brzezinski, Z. Topkarci, N. Murashkin, T. Torres, R. Epishev, A. Chiriac, T. McPherson, M. Akinde, A. Maruani, P. C. Luna, H. Vidaurri de la Cruz, S. Mallet, S. Leducq, M. Sergeant, J. Zitouni, S. K. Mahil, C. H. Smith, C. Flohr, H. Bachelez, E. Mahé, the Groupe de Recherche sur le Psoriasis (GrPso) of the Société Française de Dermatologie, the Groupe de recherche de la Société Française de Dermatologie Pédiatrique (GR SFDP), the PsoProtect study group, the British Society of Paediatric Dermatology, and the SocietàItaliana di Dermatologia Pediatrica (S.I.Der.P.) … See fewer authors
doi : 10.1111/jdv.19261
Comment on: ‘Clinical characteristics of patients with pityriasis rubra pilaris following SARS-CoV-2 vaccination’ by Gambichler
Luca Potestio, Fabrizio Martora, Alessia Villani, Matteo Megna, Angelo Ruggiero
doi : 10.1111/jdv.19264
Paradoxical joint and muscle pain in a patient treated with anifrolumab and belimumab
M. Schaeffer, D. Lipsker
doi : 10.1111/jdv.19184
First observation of dupilumab efficacy in an infant with SAM (severe dermatitis, multiple allergies and metabolic wasting) syndrome
R. W. Körner, C. Velmans, G. Dückers, I. Tantcheva-Poór
doi : 10.1111/jdv.19185
Safety profile of risankizumab in the treatment of psoriasis patients with concomitant hepatitis B or C infection: A multicentric retrospective cohort study of 49 patients
Christian Ciolfi, Riccardo Balestri, Federico Bardazzi, Martina Burlando, Karin Chersi, Antonio Costanzo, Paolo Dapavo, Paolo Gisondi, Piergiorgio Malagoli, Miriam Pizzolato, Giulia Rech, Francesco Paolo Russo, Sara Battistella, Stefano Piaserico
doi : 10.1111/jdv.19186
Effect of abrocitinib in a patient with extensive necrobiosis lipoidica
L. Arnet, C. Erfurt-Berge
doi : 10.1111/jdv.19189
Lack of effect of benralizumab on signs and symptoms of moderate-to-severe atopic dermatitis: Results from the phase 2 randomized, double-blind, placebo-controlled HILLIER trial
E. Guttman-Yassky, L. Bahadori, L. Brooks, K. L. Clark, H. Grindebacke, C. N. Ho, R. Katial, T.-H. Pham, C. Walton, C. J. Datto, the HILLIER study groupâ€Â
doi : 10.1111/jdv.19195
The transition from mild to moderate-to-severe chronic plaque psoriasis
Francesco Bellinato, Paolo Gisondi, Guido Mioso, Elena Mason, Danny Straiotto, Stefano Piaserico, Giampiero Girolomoni
doi : 10.1111/jdv.19208
Vorinostat for treatment-refractory bullous pemphigoid
Gabriela Blanchard, Francoise Solly, Valentin Basset, Lionel Fontao, Maël Blanchard, Emmanuella Guenova
doi : 10.1111/jdv.19209
Sun-protective behaviours of adult men stratified by sexual orientation: A retrospective cross-sectional analysis of National Health Interview Survey
Costner McKenzie, Akshay N. Pulavarty, John G. Zampella
doi : 10.1111/jdv.19210
Line-field confocal optical coherence tomography and reflectance confocal microscopy of Merkel cell carcinoma
S. Soglia, J. Pérez-Anker, A. Fraghì, C. Ariasi, G. La Rosa, C. Lenoir, M. Suppa, P. G. Calzavara-Pinton, M. Venturini
doi : 10.1111/jdv.19211
Minoxidil and vitamin E therapy for nail growth disorders: A retrospective study
Michela Starace, Elisa Milan, Aurora Alessandrini, Francesca Bruni, Bianca Maria Piraccini
doi : 10.1111/jdv.19213
Response rate to intramuscular ceftriaxone 1 g in patients with gonococcal infection: A French monocentric prospective study
Dorian Belakebi, Sylvain Godreuil, Marie-Christine Picot, Vincent Tribout, Cyril Perrolaz, Lisa Piccon, Ana Montoya, Marie Bistoquet, Yannick Barnier, Ã‰ric Picot, Aurélie Du-Thanh
doi : 10.1111/jdv.19214
A capricious hamartoma: Round and velvety epidermal nevus
L. M. Nieto-Benito, A. Mateos-Mayo
doi : 10.1111/jdv.19215
Line-field confocal optical coherence tomography for the diagnosis of onychomycosis in comparison with healthy nails: A case series
Sarah Hobelsberger, Julian Steininger, Andrea Bauer, Stefan Beissert, Frank Friedrich Gellrich
doi : 10.1111/jdv.19233
A retrospective study on the liver toxicity of oral retinoids in Chanarin–Dorfman syndrome
C. Valette, N. Jonca, J. Fischer, J. Pernin-Grandjean, C. Granier Tournier, A. Diociaiuti, I. Neri, I. Dreyfus, M. Furman, K. Giehl, A. Wollenberg, S. Mallet, L. Martin, A. Martin-Santiago, G. Onnis, P. Broue, S. Leclerc-Mercier, M. Schmuth, E. Sprecher, R. Gruber, K. Suessmuth, E. Bourrat, K. Komlosi, S. Hill, E. A. O'Toole, O. Schischmanoff, F. Caux, J. Mazereeuw-Hautier, the French Pediatric Dermatology Research Group and of the ‘ERN-Skin Network’
doi : 10.1111/jdv.19235
Evolution and challenges of store-and-forward teledermatology for skin diseases of elderly in long-term care facilities: Results of a 5-year analysis
Yuan Tian, Gaelle Hirsch, Charbel Skayem, Emilie Thomas, Camille Hua, Jean-Philippe David, Olivier Chosidow, Tu-Anh Duong
doi : 10.1111/jdv.19240
Clinical role of PRAME expression in melanocytic tumours: A single-centre real-world retrospective study
Leonel Hidalgo, Dominga Peirano, Francisca Donoso, SofÃÂa Villagrán, Karina Carrasco, Anthony M. Rossi, Alejandra Villarroel, Constanza Del Puerto, Miguel Villaseca-Hernández, Cristian Navarrete-Dechent
doi : 10.1111/jdv.19241
Density and diameter of dermal papillae from three different anatomical areas in normal skin using reflectance confocal microscopy
Anna Elisa Verzì, Francesco Lacarrubba, Federica Dall'Oglio, Davide Puglisi, Giuseppe Micali
doi : 10.1111/jdv.19248
Ethics in the Dermoverse: The challenge of a new technological era comment on ‘Are non-fungible tokens the barrier to realizing the Dermoverse?’
Miriam Fernández-Parrado, Héctor Perandones-González
doi : 10.1111/jdv.19249
Dermoscopic features of trichoepithelioma: A multicentre observational case–control study conducted by the International Dermoscopy Society
Caterina Longo, Nicola Lippolis, Michela Lai, Marco Spadafora, Shaniko Kaleci, Alessandra Grazia Condorelli, Mara Lombardi, Riccardo Pampena, Giuseppe Argenziano, Gianluca Nazzaro, Massimiliano Scalvenzi, Bengü Nisa Akay, Paolo Broganelli, Maria Concetta Fargnoli, John Paoli, Oriol Yélamos, Giovanni Pellacani, Stefania Borsari, Aimilios Lallas
doi : 10.1111/jdv.19262
